These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Mechanism of endothelin-induced malignant ventricular arrhythmias in dogs. Merkely B; Gellér L; Tóth M; Kiss O; Kékesi V; Solti F; Vecsey T; Horkay F; Tenczer J; Juhász-Nagy A J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S437-9. PubMed ID: 9595506 [TBL] [Abstract][Full Text] [Related]
8. Intracoronary endothelin-1 infusion combined with systemic isoproterenol treatment: antagonistic arrhythmogenic effects. Kiss O; Zima E; Soós P; Kékesi V; Juhász-Nagy A; Merkely B Life Sci; 2004 Jun; 75(5):537-48. PubMed ID: 15158364 [TBL] [Abstract][Full Text] [Related]
9. Verapamil reduces the arrhythmogenic effect of endothelin. Solti F; Tóth M; Merkely B; Kékesi V; Gellér L; Szokodi I; Horkay F; Juhász-Nagy A J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S386-7. PubMed ID: 9595491 [TBL] [Abstract][Full Text] [Related]
10. Fundamental electrophysiological differences between low-dose intracoronary endothelin-1 infusion and myocardial ischemia revealed by multiple monophasic action potential recording. Gellér L; Szabó T; Kiss O; Solti F; Juhász-Nagy A; Merkely B J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S167-71. PubMed ID: 11078368 [TBL] [Abstract][Full Text] [Related]
11. Increased monophasic action potential dispersion in endothelin-1-induced ventricular arrhythmias. Gellér L; Merkely B; Lang V; Szabó T; Fazekas L; Kékesi V; Kiss O; Horkay F; Schaldach M; Tóth M; Juhász-Nagy A J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S434-6. PubMed ID: 9595505 [TBL] [Abstract][Full Text] [Related]
12. Characterization of canine pericardial fluid endothelin-1 levels. Szokodi I; Horkay F; Kiss P; Selmeci L; Horváth I; Vuolteenaho O; Ruskoaho H; Juhász-Nagy A; Tóth M J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S399-400. PubMed ID: 9595495 [TBL] [Abstract][Full Text] [Related]
13. Investigating the dual nature of endothelin-1: ischemia or direct arrhythmogenic effect? Szabó T; Gellér L; Merkely B; Selmeci L; Juhász-Nagy A; Solti F Life Sci; 2000 May; 66(26):2527-41. PubMed ID: 10883731 [TBL] [Abstract][Full Text] [Related]
14. The selective endothelin-A-receptor antagonist LU 135.252 inhibits the direct arrhythmogenic action of endothelin-1. Merkely B; Szabó T; Gellér L; Kiss O; Horkay F; Raschack M; Juhász-Nagy A J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S314-6. PubMed ID: 11078407 [TBL] [Abstract][Full Text] [Related]
15. Expressed monophasic action potential alternans before the onset of ventricular arrhythmias induced by intracoronary bolus administration of endothelin-1 in dogs. Merkely B; Vágó H; Kiss O; Zima E; Szücs G; Gellér L; Juhász-Nagy A Clin Sci (Lond); 2002 Aug; 103 Suppl 48():219S-222S. PubMed ID: 12193090 [TBL] [Abstract][Full Text] [Related]
16. Intrapericardial adenine nucleosides induce elevation of endothelin-1 concentration in the pericardial space of the dog heart. Nagy A; Toma I; Rusvai M; Barát E; Huszár E; Juhász-Nagy A; Kékesi V J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S227-30. PubMed ID: 15838286 [TBL] [Abstract][Full Text] [Related]
17. Bradycardia increases the arrhythmogenic effect of endothelin. Tóth M; Solti F; Merkely B; Kékesi V; Szokodi I; Horkay F; Juhász-Nagy A J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S431-3. PubMed ID: 9595504 [TBL] [Abstract][Full Text] [Related]
18. Effects of intrapericardially administered endothelin-1 on pericardial natriuretic peptide concentrations of the in situ dog heart. Toma I; Nagy A; Jánosi C; Rusvai M; Juhász-Nagy A; Kékesi V J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S231-3. PubMed ID: 15838287 [TBL] [Abstract][Full Text] [Related]
19. Effects of experimental diabetes on endothelin-induced ventricular arrhythmias in dogs. Pósa I; Horkay F; Seres L; Skoumal R; Kováts T; Balogh E; de Châtel R; Tóth M; Kocsis E J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S380-2. PubMed ID: 15838325 [TBL] [Abstract][Full Text] [Related]
20. Pericardial concentrations of adenosine, inosine and hypoxanthine in an experimental canine model of spastic ischaemia. Kékesi V; Zima E; Barát E; Huszár E; Nagy A; Losonczi L; Merkely B; Horkay F; Juhász-Nagy A Clin Sci (Lond); 2002 Aug; 103 Suppl 48():198S-201S. PubMed ID: 12193085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]